Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Galdakao
Clinical trial register · Spain

Clinical Trials in Galdakao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Boehringer Ingelheim5 Fundación EPIC5 Biogipuzkoa Health Research Institute2 AbbVie2 GLSMED Learning Health S.A.2
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Galdakao

28 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Boehringer Ingelheim
Phase 3
466
Badalona, Barcelona, Córdoba, Galdakao, Granollers, Hospitalet Llobregat, L'Hospitalet de Llobregat, Madrid
2026-09-17
Recruiting
Early Cognitive Interventions in Digital Format for Cancer Survivors
NCT07729969Cognitive Impairment, Cognitive Change, Cancer
Biogipuzkoa Health Research Institute
Not applicable
110
Bilbao, Galdakao, San Sebastián
2026-06-08
Recruiting
Boehringer Ingelheim
Phase 2
405
Badalona, Barcelona, Galdakao, Madrid, Vitoria-Gasteiz
2026-04-20
Recruiting
AstraZeneca
Phase 3
245
Barcelona, Córdoba, Galdakao, Madrid, Sabadell, Santander, Seville, Valencia
2026-04-13
Recruiting
GLSMED Learning Health S.A.
Observational
10,000
Galdakao
2026-04-01
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
80
Galdakao, L'Hospitalet Del Llobregat, Madrid, Seville
2026-02-10
Recruiting
Inhaled Sedation in Critically Ill Patients
NCT07000526Sedation, Airway Extubation
DrugsIsoflurane·Propofol
Instituto de Investigación Hospital Universitario La Paz
Phase 4
620
Orihuela, Arrecife, Galdakao, Albacete, Badalona, Barcelona, Jaén, Lleida
2025-12-15
Recruiting
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
NCT07284277Pancreatic Adenocarcinoma Metastatic, Pancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2
30
Pamplona, Barakaldo, Galdakao, Madrid, Vitoria-Gasteiz
2025-10-14
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Barcelona, Ferrol, Galdakao, Gijón, Girona, Madrid, Santiago de Compostela, Seville
2025-10-01
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Badalona, Barcelona, Beiro, Córdoba, Galdakao, Huelva, Jaén, Las Palmas de Gran Canaria
2025-07-22
Recruiting
Fundación EPIC
Not applicable
128
Barcelona, Fuencarral-El Pardo, Galdakao, L'Hospitalet de Llobregat, León, Madrid, Moncloa-Aravaca, Pamplona
2024-12-17
Recruiting
Biogipuzkoa Health Research Institute
Not applicable
180
Vitoria - Gateiz, Galdakao, San Sebastián
2024-10-08
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Alicante, Barcelona, Bilbao, El Palmar, Galdakao, Granada, L'Hospitalet de Llobregat, Madrid
2024-05-06
Active, closed
AbbVie
Observational
1,200
Sant Joan Despí, Jerez de la Frontera, Córdoba, Las Palmas de Gran Canaria, Leganés, Oviedo, Galdakao, Barcelona
2024-02-19
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
A Coruña, Barcelona, Galdakao, Jaén, Jerez de la Frontera, Las Palmas, León, Santiago de Compostela
2023-07-17
Active, closed
AbbVie
Observational
785
L'Hospitalet de Llobregat, Sabadell, Las Palmas de Gran Canaria, Gijón, San Cristóbal de La Laguna, Seville, Galdakao, Almería
2022-08-15
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Galdakao, Málaga, Barcelona, Córdoba, Lugo, Madrid, Oviedo, Salamanca
2022-04-20
Active, closed
Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients
NCT05193019Ischemic Heart Disease, Acute Coronary Syndrome
Fundación EPIC
Observational
717
L'Hospitalet de Llobregat, Barakaldo, Galdakao, Gijón, León, Madrid, Pamplona, Salamanca
2022-03-14
Recruiting
National GMA Post-market Clinical Follow-up Study (GRACE)
NCT05636709Crohn Disease, Ulcerative Colitis
Adacyte Therapeutics SL
Observational
350
Albacete, Alicante, Badalona, Barcelona, Galdakao, Castellon, Cadiz, Córdoba
2022-01-11
Active, closed
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
NCT04899141Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
400
Málaga, Barakaldo, Barcelona, Cáceres, Ciudad Real, Donostia / San Sebastian, Elche, Galdakao
2021-10-29
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Badalona, Barcelona, Cartagena, Galdakao, Madrid, Seville, Valencia
2021-08-04
Active, closed
GLSMED Learning Health S.A.
Not applicable
533
Barcelona, Galdakao, Vigo
2021-08-01
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Barcelona, Valladolid, Bilbao, Galdakao, Jaén, Madrid, Manresa, Sabadell
2021-04-24
Active, closed
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197Coronary Occlusion, Left Main Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease
Fundación EPIC
Not applicable
400
Badalona, Barakaldo, Donostia / San Sebastian, Málaga, Galdakao, A Coruña, Albacete, Alicante
2021-04-16
Recruiting
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NCT03711110Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Elderly, Antineoplastic Agents, Cardiotoxicity
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Not applicable
514
Santiago de Compostela, Galdakao, Barcelona, Córdoba, Madrid, Málaga, Salamanca, Seville
2019-08-02
Active, closed
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
NCT03767621Coronary Artery Disease, Left Main Coronary Artery Stenosis, Left Main Coronary Artery Disease, Restenosis, Coronary
Fundación EPIC
Observational
300
Terrassa, Cartagena, El Palmar, Castellon, Galdakao, Albacete, Badajoz, Badalona
2019-02-19
Recruiting
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NCT03563417Ischemic Heart Disease, Chronic Total Occlusion of Coronary Artery
Aarhus University Hospital Skejby
Not applicable
1,560
Badalona, Galdakao, Barcelona, Madrid, Tarragona
2018-11-06
Active, closed
Jesus Moreta Suarez
Not applicable
200
Galdakao
2015-06
Rows per page Showing 1–28 of 28
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/galdakao

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 28 of those studies with a site in Galdakao.

How many clinical trials are recruiting in Galdakao?

18 of the 28 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Galdakao), 28 studies
PhaseStudiesRecruitingShare
Not applicable9632.1%
Observational8328.6%
Phase 37525%
Phase 1/2113.6%
Phase 2113.6%
Phase 2/3113.6%
Phase 4113.6%

Most active sponsors

Lead sponsors with the most studies (Galdakao)
Lead sponsorStudiesRecruiting
Boehringer Ingelheim54
Fundación EPIC51
AbbVie20
Biogipuzkoa Health Research Institute22
GLSMED Learning Health S.A.21
Aarhus University Hospital Skejby11
Adacyte Therapeutics SL11
AgNovos Healthcare, LLC11
Assistance Publique - Hôpitaux de Paris10
AstraZeneca11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.